A Dose-range Finding Study of MAA868 in Patients With Atrial Fibrillation
Clinical trial NCT04213807 · COMPLETED
Trial details
- NCT number
- NCT04213807
- Sponsor
- Anthos Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-11
- Primary completion
- 2020-12-29
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.